This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Campus
  1. Resource
  2. Source: Campus Sanofi
  3. 1 Nov 2024

Praluent® (alirocumab) - Comprehensive Support for the Praluent® Patient

Author: Sanofi

Editorial Team

Praluent logo

Disclaimer: The resources contained within this section are updated regularly by Sanofi. Before you use any of the resources, or provide any resources to your patients please re-visit this page to ensure that you are using the most up-to-date version(s).

Patient Resources

RESOURCES FOR PRALUENT® 75MG OR 150MG

▶ Digital Starter Pack (PDF)

▶ Praluent® Injection Guide (PDF)

▶ Living with High Cholesterol (PDF)

1/3

▶ Digital Starter Pack (PDF)

▶ Praluent® Injection Guide (PDF)

▶ Living with High Cholesterol (PDF)

▶ How to Inject Praluent® (video)

RESOURCES FOR PRALUENT® 300MG

▶ Digital Starter Pack (PDF)

▶ Praluent® Injection Guide (PDF)

▶ Living with High Cholesterol (PDF)

1/3

▶ Digital Starter Pack (PDF)

▶ Praluent® Injection Guide (PDF)

▶ Living with High Cholesterol (PDF)

▶ How to Inject Praluent® (video)

Patient Profiles

Homecare

Read the patients profiles you are likely to encounter in your practice who could be eligible for Praluent®.

Homecare is run by experienced pharmacists who dispense Praluent® and arrange delivery to patients.

MyPraluent® Coach

MyPraluent® Coach is a free 6-12 month programme designed with input from healthcare professionals and patients prescribed Praluent® and is delivered by experienced nurses.

Praluent®

Find more information on Indication, Administration and Mechanism of Action and watch videos about Praluent®.

Patient Website

Find resources and support for your patients on Praluent®. Find useful links about how patients can manage their cholesterol.

Get in touch with the Dyslipidaemia Team
MAT-XU-2201545 (v5.0) Date of Preparation: October 2023
References
  1. Schwartz G, et al. N Engl J Med 2018;379(22):2097–2107.

MAT-XU-2204602 (v8.0) Date of Preparation: November 2024